ArticleSurgery today2017
The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment.
Ryuma Tokunaga et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled ittrialcites it